The Zepbound LillyDirect offers comes in a single-dose vial rather than as an auto-injector pen, also called a Zepbound pen. The vial doses available are 2.5 mg and 5 mg, which is limited compared ...
A diabetes drug may beat costly shots for patients with a rare genetic condition, according to a Rutgers Health study.
Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...
while Wegovy is a weekly injection. Do you need a prescription for Zepbound? Yes, you need a prescription for Zepbound. Prescriptions can typically be written by licensed healthcare professionals ...
Eli Lilly will announce Q4 2024 results, with analysts estimating $13.7 billion in sales and $4.94 EPS, alongside a revenue growth outlook for 2024.
Novo Nordisk's CagriSema trial raised concerns as patients reported weight loss but significant side effects. Investors ...
During his appearance on the " Armchair Expert " podcast on Monday, the "Frozen" actor opened up about taking weight loss ...
The offerings reflect an increase in IPO activity that could continue, as four other biotechs recently outlined plans to go ...
An experimental drug called amycretin showed signs it could be more potent than Eli Lilly’s rival Zepbound, though analysts ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results